221 related articles for article (PubMed ID: 27457702)
1. Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression.
Gonsalves WI; Rajkumar SV; Dispenzieri A; Dingli D; Timm MM; Morice WG; Lacy MQ; Buadi FK; Go RS; Leung N; Kapoor P; Hayman SR; Lust JA; Russell SJ; Zeldenrust SR; Hwa L; Kourelis TV; Kyle RA; Gertz MA; Kumar SK
Leukemia; 2017 Jan; 31(1):130-135. PubMed ID: 27457702
[TBL] [Abstract][Full Text] [Related]
2. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C
Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877
[TBL] [Abstract][Full Text] [Related]
3. Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.
Gonsalves WI; Rajkumar SV; Gupta V; Morice WG; Timm MM; Singh PP; Dispenzieri A; Buadi FK; Lacy MQ; Kapoor P; Gertz MA; Kumar SK
Leukemia; 2014 Oct; 28(10):2060-5. PubMed ID: 24618735
[TBL] [Abstract][Full Text] [Related]
4. Quantification of clonal circulating plasma cells in relapsed multiple myeloma.
Gonsalves WI; Morice WG; Rajkumar V; Gupta V; Timm MM; Dispenzieri A; Buadi FK; Lacy MQ; Singh PP; Kapoor P; Gertz MA; Kumar SK
Br J Haematol; 2014 Nov; 167(4):500-5. PubMed ID: 25113422
[TBL] [Abstract][Full Text] [Related]
5. High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.
Bianchi G; Kyle RA; Larson DR; Witzig TE; Kumar S; Dispenzieri A; Morice WG; Rajkumar SV
Leukemia; 2013 Mar; 27(3):680-5. PubMed ID: 22902364
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
Gonsalves WI; Jevremovic D; Nandakumar B; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Warsame R; Kourelis TV; Russell S; Lust JA; Lin Y; Go RS; Siddiqui MA; Kyle RA; Gertz MA; Rajkumar SV; Kumar SK
Am J Hematol; 2020 Mar; 95(3):310-315. PubMed ID: 31867775
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating plasma cells in peripheral blood using deep learning-based morphological analysis.
Chen P; Zhang L; Cao X; Jin X; Chen N; Zhang L; Zhu J; Pan B; Wang B; Guo W
Cancer; 2024 May; 130(10):1884-1893. PubMed ID: 38236717
[TBL] [Abstract][Full Text] [Related]
8. Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation.
Chakraborty R; Muchtar E; Kumar SK; Jevremovic D; Buadi FK; Dingli D; Dispenzieri A; Hayman SR; Hogan WJ; Kapoor P; Lacy MQ; Leung N; Gertz MA
Haematologica; 2017 Aug; 102(8):1439-1445. PubMed ID: 28473618
[TBL] [Abstract][Full Text] [Related]
9. Old and new immunophenotypic markers in multiple myeloma for discrimination of responding and relapsing patients: The importance of "normal" residual plasma cell analysis.
Pojero F; Casuccio A; Parrino MF; Cardinale G; Colonna Romano G; Caruso C; Gervasi F
Cytometry B Clin Cytom; 2015; 88(3):165-82. PubMed ID: 25529228
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma.
Gonsalves WI; Timm MM; Rajkumar SV; Morice WG; Dispenzieri A; Buadi FK; Lacy MQ; Dingli D; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
Leuk Res; 2016 May; 44():32-9. PubMed ID: 26994849
[TBL] [Abstract][Full Text] [Related]
11. Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).
Sanoja-Flores L; Flores-Montero J; Garcés JJ; Paiva B; Puig N; García-Mateo A; García-Sánchez O; Corral-Mateos A; Burgos L; Blanco E; Hernández-Martín J; Pontes R; Díez-Campelo M; Millacoy P; Rodríguez-Otero P; Prosper F; Merino J; Vidriales MB; García-Sanz R; Romero A; Palomera L; Ríos-Tamayo R; Pérez-Andrés M; Blanco JF; González M; van Dongen JJM; Durie B; Mateos MV; San-Miguel J; Orfao A;
Blood Cancer J; 2018 Nov; 8(12):117. PubMed ID: 30455467
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
[TBL] [Abstract][Full Text] [Related]
13. Should we be routinely testing for circulating clonal plasma cells in patients with multiple myeloma?
Came N
Cytometry B Clin Cytom; 2018 Sep; 94(5):559. PubMed ID: 30240163
[No Abstract] [Full Text] [Related]
14. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
Hillengass J; Moehler T; Hundemer M
Recent Results Cancer Res; 2011; 183():113-31. PubMed ID: 21509683
[TBL] [Abstract][Full Text] [Related]
15. Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders.
Foulk B; Schaffer M; Gross S; Rao C; Smirnov D; Connelly MC; Chaturvedi S; Reddy M; Brittingham G; Mata M; Repollet M; Rojas C; Auclair D; DeRome M; ; Weiss B; Sasser AK
Br J Haematol; 2018 Jan; 180(1):71-81. PubMed ID: 29105742
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis.
Liu X; Wu F; Ye W; Deng J; Zhang M; Zhang C; Yu Q; Cao L; Gan S; Ma J
BMJ Open; 2024 Jan; 14(1):e071548. PubMed ID: 38216195
[TBL] [Abstract][Full Text] [Related]
17. Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.
González-Calle V; Dávila J; Escalante F; de Coca AG; Aguilera C; López R; Bárez A; Alonso JM; Hernández R; Hernández JM; de la Fuente P; Puig N; Ocio EM; Gutiérrez NC; García-Sanz R; Mateos MV
Leukemia; 2016 Oct; 30(10):2026-2031. PubMed ID: 27133826
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of circulating clonal plasma cells in newly diagnosed multiple myeloma.
Han W; Jin Y; Xu M; Zhao SS; Shi Q; Qu X; Zhang R; Li J; Wu Y; Chen L
Hematology; 2021 Dec; 26(1):510-517. PubMed ID: 34314294
[TBL] [Abstract][Full Text] [Related]
19. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.
Paiva B; Almeida J; Pérez-Andrés M; Mateo G; López A; Rasillo A; Vídriales MB; López-Berges MC; Miguel JF; Orfao A
Cytometry B Clin Cytom; 2010 Jul; 78(4):239-52. PubMed ID: 20155853
[TBL] [Abstract][Full Text] [Related]
20. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.
Paiva B; Vídriales MB; Rosiñol L; Martínez-López J; Mateos MV; Ocio EM; Montalbán MÁ; Cordón L; Gutiérrez NC; Corchete L; Oriol A; Terol MJ; Echeveste MA; De Paz R; De Arriba F; Palomera L; de la Rubia J; Díaz-Mediavilla J; Granell M; Gorosquieta A; Alegre A; Orfao A; Lahuerta JJ; Bladé J; San Miguel JF;
Leukemia; 2013 Oct; 27(10):2056-61. PubMed ID: 23743858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
